Compare Chevron Corp (CVX) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chevron Corp vs Revvity Inc — how do they compare? Chevron Corp trades at $195.58 (market cap $385.65B), while Revvity Inc trades at $118.14 (market cap $13.15B). The key difference: Chevron Corp is far larger — about 29.3× Revvity Inc's market cap, and Chevron Corp pays the higher dividend (3.62%). Which is the better fit depends on your goals.
| CVX | RVTY | |
|---|---|---|
Market Cap | $385.65B | $13.15B |
Volume | 9,807,834 | — |
Sector | Energy | Technology |
52-Week High | $211.14 | $117.88 |
52-Week Low | $146.72 | $82.26 |
Enterprise Value | $414.20B | $15.47B |
Dividend Yield | 3.62% | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVX trades at $196.66, up 0.9% today, with a bullish technical signal supported by moving averages. The stock has beaten EPS estimates in recent quarters, though revenue and net income have declined from 2022 peaks. Analyst consensus is strongly bullish with a $214.25 price target, and the company maintains solid profitability with a 9.87% net margin and 12.25% ROE. Recent news highlights Chevron's $13.8 billion investment in Argentina's Vaca Muerta shale and geopolitical factors affecting oil prices.
Outlook remains positive driven by high oil prices and strategic investments, but risks include volatile energy markets and execution of large capital projects. The stock offers value with a P/E of 18.93 and consistent dividends, though investors face headwinds from declining profit margins and geopolitical tensions impacting global supply chains.
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chevron Corp
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
